FABP3 and synucleinopathy: Although FABP3 has been suggested to promote αSyn aggregation in animal models and to potentially be a useful biomarker for synucleinopathies, it remains to be elucidated whether FABP3 accumulation is associated with αSyn aggregation in human tissues.